Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 9 of 9 entries
Sorted by: Best Match Show Resources per page
The human cytomegalovirus protein pUL13 targets mitochondrial cristae architecture to increase cellular respiration during infection.

Proceedings of the National Academy of Sciences of the United States of America

Betsinger CN, Jankowski CSR, Hofstadter WA, Federspiel JD, Otter CJ, Jean Beltran PM, Cristea IM.
PMID: 34344827
Proc Natl Acad Sci U S A. 2021 Aug 10;118(32). doi: 10.1073/pnas.2101675118.

Viruses modulate mitochondrial processes during infection to increase biosynthetic precursors and energy output, fueling virus replication. In a surprising fashion, although it triggers mitochondrial fragmentation, the prevalent pathogen human cytomegalovirus (HCMV) increases mitochondrial metabolism through a yet-unknown mechanism. Here,...

Cite
Betsinger CN, Jankowski CSR, Hofstadter WA, et al. The human cytomegalovirus protein pUL13 targets mitochondrial cristae architecture to increase cellular respiration during infection. Proc Natl Acad Sci U S A. 2021;118(32)doi: 10.1073/pnas.2101675118.
Betsinger, C. N., Jankowski, C. S. R., Hofstadter, W. A., Federspiel, J. D., Otter, C. J., Jean Beltran, P. M., & Cristea, I. M. (2021). The human cytomegalovirus protein pUL13 targets mitochondrial cristae architecture to increase cellular respiration during infection. Proceedings of the National Academy of Sciences of the United States of America, 118(32), . https://doi.org/10.1073/pnas.2101675118
Betsinger, Cora N, et al. "The human cytomegalovirus protein pUL13 targets mitochondrial cristae architecture to increase cellular respiration during infection." Proceedings of the National Academy of Sciences of the United States of America vol. 118,32 (2021). doi: https://doi.org/10.1073/pnas.2101675118
Betsinger CN, Jankowski CSR, Hofstadter WA, Federspiel JD, Otter CJ, Jean Beltran PM, Cristea IM. The human cytomegalovirus protein pUL13 targets mitochondrial cristae architecture to increase cellular respiration during infection. Proc Natl Acad Sci U S A. 2021 Aug 10;118(32). doi: 10.1073/pnas.2101675118. PMID: 34344827; PMCID: PMC8364163.
Copy Download .nbib Format: NLM
Proximity-Labeling Reveals Novel Host and Parasite Proteins at the .

mBio

Cygan AM, Jean Beltran PM, Mendoza AG, Branon TC, Ting AY, Carr SA, Boothroyd JC.
PMID: 34749525
mBio. 2021 Dec 21;12(6):e0026021. doi: 10.1128/mBio.00260-21. Epub 2021 Nov 09.

Toxoplasma gondii is a ubiquitous, intracellular parasite that envelops its parasitophorous vacuole with a protein-laden membrane (PVM). The PVM is critical for interactions with the infected host cell, such as nutrient transport and immune defense. Only a few parasite...

Cite
Cygan AM, Jean Beltran PM, Mendoza AG, et al. Proximity-Labeling Reveals Novel Host and Parasite Proteins at the . mBio. 2021;12(6):e0026021doi: 10.1128/mBio.00260-21.
Cygan, A. M., Jean Beltran, P. M., Mendoza, A. G., Branon, T. C., Ting, A. Y., Carr, S. A., & Boothroyd, J. C. (2021). Proximity-Labeling Reveals Novel Host and Parasite Proteins at the . mBio, 12(6), e0026021. https://doi.org/10.1128/mBio.00260-21
Cygan, Alicja M, et al. "Proximity-Labeling Reveals Novel Host and Parasite Proteins at the ." mBio vol. 12,6 (2021): e0026021. doi: https://doi.org/10.1128/mBio.00260-21
Cygan AM, Jean Beltran PM, Mendoza AG, Branon TC, Ting AY, Carr SA, Boothroyd JC. Proximity-Labeling Reveals Novel Host and Parasite Proteins at the . mBio. 2021 Dec 21;12(6):e0026021. doi: 10.1128/mBio.00260-21. Epub 2021 Nov 09. PMID: 34749525; PMCID: PMC8576527.
Copy Download .nbib Format: NLM
Proximity-Labeling Reveals Novel Host and Parasite Proteins at the .

mBio

Cygan AM, Jean Beltran PM, Mendoza AG, Branon TC, Ting AY, Carr SA, Boothroyd JC.
PMID: 34749525
mBio. 2021 Nov 09;e0026021. doi: 10.1128/mBio.00260-21. Epub 2021 Nov 09.

Toxoplasma gondii is a ubiquitous, intracellular parasite that envelops its parasitophorous vacuole with a protein-laden membrane (PVM). The PVM is critical for interactions with the infected host cell, such as nutrient transport and immune defense. Only a few parasite...

Cite
Cygan AM, Jean Beltran PM, Mendoza AG, et al. Proximity-Labeling Reveals Novel Host and Parasite Proteins at the . mBio. 2021;e0026021doi: 10.1128/mBio.00260-21.
Cygan, A. M., Jean Beltran, P. M., Mendoza, A. G., Branon, T. C., Ting, A. Y., Carr, S. A., & Boothroyd, J. C. (2021). Proximity-Labeling Reveals Novel Host and Parasite Proteins at the . mBio, e0026021. https://doi.org/10.1128/mBio.00260-21
Cygan, Alicja M, et al. "Proximity-Labeling Reveals Novel Host and Parasite Proteins at the ." mBio vol. (2021): e0026021. doi: https://doi.org/10.1128/mBio.00260-21
Cygan AM, Jean Beltran PM, Mendoza AG, Branon TC, Ting AY, Carr SA, Boothroyd JC. Proximity-Labeling Reveals Novel Host and Parasite Proteins at the . mBio. 2021 Nov 09;e0026021. doi: 10.1128/mBio.00260-21. Epub 2021 Nov 09. PMID: 34749525; PMCID: PMC8576527.
Copy Download .nbib Format: NLM
A highly multiplexed quantitative phosphosite assay for biology and preclinical studies.

Molecular systems biology

Keshishian H, McDonald ER, Mundt F, Melanson R, Krug K, Porter DA, Wallace L, Forestier D, Rabasha B, Marlow SE, Jane-Valbuena J, Todres E, Specht H, Robinson ML, Jean Beltran PM, Babur O, Olive ME, Golji J, Kuhn E, Burgess M, MacMullan MA, Rejtar T, Wang K, Mani DR, Satpathy S, Gillette MA, Sellers WR, Carr SA.
PMID: 34569154
Mol Syst Biol. 2021 Sep;17(9):e10156. doi: 10.15252/msb.202010156.

Reliable methods to quantify dynamic signaling changes across diverse pathways are needed to better understand the effects of disease and drug treatment in cells and tissues but are presently lacking. Here, we present SigPath, a targeted mass spectrometry (MS)...

Cite
Keshishian H, McDonald ER, Mundt F, et al. A highly multiplexed quantitative phosphosite assay for biology and preclinical studies. Mol Syst Biol. 2021;17(9):e10156doi: 10.15252/msb.202010156.
Keshishian, H., McDonald, E. R., Mundt, F., Melanson, R., Krug, K., Porter, D. A., Wallace, L., Forestier, D., Rabasha, B., Marlow, S. E., Jane-Valbuena, J., Todres, E., Specht, H., Robinson, M. L., Jean Beltran, P. M., Babur, O., Olive, M. E., Golji, J., Kuhn, E., Burgess, M., MacMullan, M. A., Rejtar, T., Wang, K., Mani, D. R., Satpathy, S., Gillette, M. A., Sellers, W. R., & Carr, S. A. (2021). A highly multiplexed quantitative phosphosite assay for biology and preclinical studies. Molecular systems biology, 17(9), e10156. https://doi.org/10.15252/msb.202010156
Keshishian, Hasmik, et al. "A highly multiplexed quantitative phosphosite assay for biology and preclinical studies." Molecular systems biology vol. 17,9 (2021): e10156. doi: https://doi.org/10.15252/msb.202010156
Keshishian H, McDonald ER, Mundt F, Melanson R, Krug K, Porter DA, Wallace L, Forestier D, Rabasha B, Marlow SE, Jane-Valbuena J, Todres E, Specht H, Robinson ML, Jean Beltran PM, Babur O, Olive ME, Golji J, Kuhn E, Burgess M, MacMullan MA, Rejtar T, Wang K, Mani DR, Satpathy S, Gillette MA, Sellers WR, Carr SA. A highly multiplexed quantitative phosphosite assay for biology and preclinical studies. Mol Syst Biol. 2021 Sep;17(9):e10156. doi: 10.15252/msb.202010156. PMID: 34569154; PMCID: PMC8474009.
Copy Download .nbib Format: NLM
A proteogenomic portrait of lung squamous cell carcinoma.

Cell

Satpathy S, Krug K, Jean Beltran PM, Savage SR, Petralia F, Kumar-Sinha C, Dou Y, Reva B, Kane MH, Avanessian SC, Vasaikar SV, Krek A, Lei JT, Jaehnig EJ, Omelchenko T, Geffen Y, Bergstrom EJ, Stathias V, Christianson KE, Heiman DI, Cieslik MP, Cao S, Song X, Ji J, Liu W, Li K, Wen B, Li Y, Gümüş ZH, Selvan ME, Soundararajan R, Visal TH, Raso MG, Parra ER, Babur Ö, Vats P, Anand S, Schraink T, Cornwell M, Rodrigues FM, Zhu H, Mo CK, Zhang Y, da Veiga Leprevost F, Huang C, Chinnaiyan AM, Wyczalkowski MA, Omenn GS, Newton CJ, Schurer S, Ruggles KV, Fenyö D, Jewell SD, Thiagarajan M, Mesri M, Rodriguez H, Mani SA, Udeshi ND, Getz G, Suh J, Li QK, Hostetter G, Paik PK, Dhanasekaran SM, Govindan R, Ding L, Robles AI, Clauser KR, Nesvizhskii AI, Wang P, Carr SA, Zhang B, Mani DR, Gillette MA.
PMID: 34358469
Cell. 2021 Aug 05;184(16):4348-4371.e40. doi: 10.1016/j.cell.2021.07.016.

Lung squamous cell carcinoma (LSCC) remains a leading cause of cancer death with few therapeutic options. We characterized the proteogenomic landscape of LSCC, providing a deeper exposition of LSCC biology with potential therapeutic implications. We identify NSD3 as an...

Cite
Satpathy S, Krug K, Jean Beltran PM, et al. A proteogenomic portrait of lung squamous cell carcinoma. Cell. 2021;184(16):4348-4371.e40doi: 10.1016/j.cell.2021.07.016.
Satpathy, S., Krug, K., Jean Beltran, P. M., Savage, S. R., Petralia, F., Kumar-Sinha, C., Dou, Y., Reva, B., Kane, M. H., Avanessian, S. C., Vasaikar, S. V., Krek, A., Lei, J. T., Jaehnig, E. J., Omelchenko, T., Geffen, Y., Bergstrom, E. J., Stathias, V., Christianson, K. E., Heiman, D. I., Cieslik, M. P., Cao, S., Song, X., Ji, J., Liu, W., Li, K., Wen, B., Li, Y., Gümüş, Z. H., Selvan, M. E., Soundararajan, R., Visal, T. H., Raso, M. G., Parra, E. R., Babur, �. �., Vats, P., Anand, S., Schraink, T., Cornwell, M., Rodrigues, F. M., Zhu, H., Mo, C. K., Zhang, Y., da Veiga Leprevost, F., Huang, C., Chinnaiyan, A. M., Wyczalkowski, M. A., Omenn, G. S., Newton, C. J., Schurer, S., Ruggles, K. V., Fenyö, D., Jewell, S. D., Thiagarajan, M., Mesri, M., Rodriguez, H., Mani, S. A., Udeshi, N. D., Getz, G., Suh, J., Li, Q. K., Hostetter, G., Paik, P. K., Dhanasekaran, S. M., Govindan, R., Ding, L., Robles, A. I., Clauser, K. R., Nesvizhskii, A. I., Wang, P., Carr, S. A., Zhang, B., Mani, D. R., Gillette, M. A. (2021). A proteogenomic portrait of lung squamous cell carcinoma. Cell, 184(16), 4348-4371.e40. https://doi.org/10.1016/j.cell.2021.07.016
Satpathy, Shankha, et al. "A proteogenomic portrait of lung squamous cell carcinoma." Cell vol. 184,16 (2021): 4348-4371.e40. doi: https://doi.org/10.1016/j.cell.2021.07.016
Satpathy S, Krug K, Jean Beltran PM, Savage SR, Petralia F, Kumar-Sinha C, Dou Y, Reva B, Kane MH, Avanessian SC, Vasaikar SV, Krek A, Lei JT, Jaehnig EJ, Omelchenko T, Geffen Y, Bergstrom EJ, Stathias V, Christianson KE, Heiman DI, Cieslik MP, Cao S, Song X, Ji J, Liu W, Li K, Wen B, Li Y, Gümüş ZH, Selvan ME, Soundararajan R, Visal TH, Raso MG, Parra ER, Babur Ö, Vats P, Anand S, Schraink T, Cornwell M, Rodrigues FM, Zhu H, Mo CK, Zhang Y, da Veiga Leprevost F, Huang C, Chinnaiyan AM, Wyczalkowski MA, Omenn GS, Newton CJ, Schurer S, Ruggles KV, Fenyö D, Jewell SD, Thiagarajan M, Mesri M, Rodriguez H, Mani SA, Udeshi ND, Getz G, Suh J, Li QK, Hostetter G, Paik PK, Dhanasekaran SM, Govindan R, Ding L, Robles AI, Clauser KR, Nesvizhskii AI, Wang P, Carr SA, Zhang B, Mani DR, Gillette MA. A proteogenomic portrait of lung squamous cell carcinoma. Cell. 2021 Aug 05;184(16):4348-4371.e40. doi: 10.1016/j.cell.2021.07.016. PMID: 34358469; PMCID: PMC8475722.
Copy Download .nbib Format: NLM
Proximity-Labeling Reveals Novel Host and Parasite Proteins at the .

mBio

Cygan AM, Jean Beltran PM, Mendoza AG, Branon TC, Ting AY, Carr SA, Boothroyd JC.
PMID: 34749525
mBio. 2021 Dec 21;12(6):e0026021. doi: 10.1128/mBio.00260-21. Epub 2021 Nov 09.

Toxoplasma gondii is a ubiquitous, intracellular parasite that envelops its parasitophorous vacuole with a protein-laden membrane (PVM). The PVM is critical for interactions with the infected host cell, such as nutrient transport and immune defense. Only a few parasite...

Cite
Cygan AM, Jean Beltran PM, Mendoza AG, et al. Proximity-Labeling Reveals Novel Host and Parasite Proteins at the . mBio. 2021;12(6):e0026021doi: 10.1128/mBio.00260-21.
Cygan, A. M., Jean Beltran, P. M., Mendoza, A. G., Branon, T. C., Ting, A. Y., Carr, S. A., & Boothroyd, J. C. (2021). Proximity-Labeling Reveals Novel Host and Parasite Proteins at the . mBio, 12(6), e0026021. https://doi.org/10.1128/mBio.00260-21
Cygan, Alicja M, et al. "Proximity-Labeling Reveals Novel Host and Parasite Proteins at the ." mBio vol. 12,6 (2021): e0026021. doi: https://doi.org/10.1128/mBio.00260-21
Cygan AM, Jean Beltran PM, Mendoza AG, Branon TC, Ting AY, Carr SA, Boothroyd JC. Proximity-Labeling Reveals Novel Host and Parasite Proteins at the . mBio. 2021 Dec 21;12(6):e0026021. doi: 10.1128/mBio.00260-21. Epub 2021 Nov 09. PMID: 34749525; PMCID: PMC8576527.
Copy Download .nbib Format: NLM
A proteogenomic portrait of lung squamous cell carcinoma.

Cell

Satpathy S, Krug K, Jean Beltran PM, Savage SR, Petralia F, Kumar-Sinha C, Dou Y, Reva B, Kane MH, Avanessian SC, Vasaikar SV, Krek A, Lei JT, Jaehnig EJ, Omelchenko T, Geffen Y, Bergstrom EJ, Stathias V, Christianson KE, Heiman DI, Cieslik MP, Cao S, Song X, Ji J, Liu W, Li K, Wen B, Li Y, Gümüş ZH, Selvan ME, Soundararajan R, Visal TH, Raso MG, Parra ER, Babur Ö, Vats P, Anand S, Schraink T, Cornwell M, Rodrigues FM, Zhu H, Mo CK, Zhang Y, da Veiga Leprevost F, Huang C, Chinnaiyan AM, Wyczalkowski MA, Omenn GS, Newton CJ, Schurer S, Ruggles KV, Fenyö D, Jewell SD, Thiagarajan M, Mesri M, Rodriguez H, Mani SA, Udeshi ND, Getz G, Suh J, Li QK, Hostetter G, Paik PK, Dhanasekaran SM, Govindan R, Ding L, Robles AI, Clauser KR, Nesvizhskii AI, Wang P, Carr SA, Zhang B, Mani DR, Gillette MA.
PMID: 34358469
Cell. 2021 Aug 05;184(16):4348-4371.e40. doi: 10.1016/j.cell.2021.07.016.

Lung squamous cell carcinoma (LSCC) remains a leading cause of cancer death with few therapeutic options. We characterized the proteogenomic landscape of LSCC, providing a deeper exposition of LSCC biology with potential therapeutic implications. We identify NSD3 as an...

Cite
Satpathy S, Krug K, Jean Beltran PM, et al. A proteogenomic portrait of lung squamous cell carcinoma. Cell. 2021;184(16):4348-4371.e40doi: 10.1016/j.cell.2021.07.016.
Satpathy, S., Krug, K., Jean Beltran, P. M., Savage, S. R., Petralia, F., Kumar-Sinha, C., Dou, Y., Reva, B., Kane, M. H., Avanessian, S. C., Vasaikar, S. V., Krek, A., Lei, J. T., Jaehnig, E. J., Omelchenko, T., Geffen, Y., Bergstrom, E. J., Stathias, V., Christianson, K. E., Heiman, D. I., Cieslik, M. P., Cao, S., Song, X., Ji, J., Liu, W., Li, K., Wen, B., Li, Y., Gümüş, Z. H., Selvan, M. E., Soundararajan, R., Visal, T. H., Raso, M. G., Parra, E. R., Babur, �. �., Vats, P., Anand, S., Schraink, T., Cornwell, M., Rodrigues, F. M., Zhu, H., Mo, C. K., Zhang, Y., da Veiga Leprevost, F., Huang, C., Chinnaiyan, A. M., Wyczalkowski, M. A., Omenn, G. S., Newton, C. J., Schurer, S., Ruggles, K. V., Fenyö, D., Jewell, S. D., Thiagarajan, M., Mesri, M., Rodriguez, H., Mani, S. A., Udeshi, N. D., Getz, G., Suh, J., Li, Q. K., Hostetter, G., Paik, P. K., Dhanasekaran, S. M., Govindan, R., Ding, L., Robles, A. I., Clauser, K. R., Nesvizhskii, A. I., Wang, P., Carr, S. A., Zhang, B., Mani, D. R., Gillette, M. A. (2021). A proteogenomic portrait of lung squamous cell carcinoma. Cell, 184(16), 4348-4371.e40. https://doi.org/10.1016/j.cell.2021.07.016
Satpathy, Shankha, et al. "A proteogenomic portrait of lung squamous cell carcinoma." Cell vol. 184,16 (2021): 4348-4371.e40. doi: https://doi.org/10.1016/j.cell.2021.07.016
Satpathy S, Krug K, Jean Beltran PM, Savage SR, Petralia F, Kumar-Sinha C, Dou Y, Reva B, Kane MH, Avanessian SC, Vasaikar SV, Krek A, Lei JT, Jaehnig EJ, Omelchenko T, Geffen Y, Bergstrom EJ, Stathias V, Christianson KE, Heiman DI, Cieslik MP, Cao S, Song X, Ji J, Liu W, Li K, Wen B, Li Y, Gümüş ZH, Selvan ME, Soundararajan R, Visal TH, Raso MG, Parra ER, Babur Ö, Vats P, Anand S, Schraink T, Cornwell M, Rodrigues FM, Zhu H, Mo CK, Zhang Y, da Veiga Leprevost F, Huang C, Chinnaiyan AM, Wyczalkowski MA, Omenn GS, Newton CJ, Schurer S, Ruggles KV, Fenyö D, Jewell SD, Thiagarajan M, Mesri M, Rodriguez H, Mani SA, Udeshi ND, Getz G, Suh J, Li QK, Hostetter G, Paik PK, Dhanasekaran SM, Govindan R, Ding L, Robles AI, Clauser KR, Nesvizhskii AI, Wang P, Carr SA, Zhang B, Mani DR, Gillette MA. A proteogenomic portrait of lung squamous cell carcinoma. Cell. 2021 Aug 05;184(16):4348-4371.e40. doi: 10.1016/j.cell.2021.07.016. PMID: 34358469; PMCID: PMC8475722.
Copy Download .nbib Format: NLM
Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies.

Blood cancer discovery

Renneville A, Gasser JA, Grinshpun DE, Jean Beltran PM, Udeshi ND, Matyskiela ME, Clayton T, McConkey M, Viswanathan K, Tepper A, Guirguis AA, Sellar RS, Cotteret S, Marzac C, Saada V, De Botton S, Kiladjian JJ, Cayuela JM, Rolfe M, Chamberlain PP, Carr SA, Ebert BL.
PMID: 34027417
Blood Cancer Discov. 2021 May;2(3):250-265. doi: 10.1158/2643-3230.bcd-20-0105. Epub 2021 Mar 10.

Thalidomide analogs exert their therapeutic effects by binding to the CRL4

Cite
Renneville A, Gasser JA, Grinshpun DE, et al. Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies. Blood Cancer Discov. 2021;2(3):250-265doi: 10.1158/2643-3230.bcd-20-0105.
Renneville, A., Gasser, J. A., Grinshpun, D. E., Jean Beltran, P. M., Udeshi, N. D., Matyskiela, M. E., Clayton, T., McConkey, M., Viswanathan, K., Tepper, A., Guirguis, A. A., Sellar, R. S., Cotteret, S., Marzac, C., Saada, V., De Botton, S., Kiladjian, J. J., Cayuela, J. M., Rolfe, M., Chamberlain, P. P., Carr, S. A., & Ebert, B. L. (2021). Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies. Blood cancer discovery, 2(3), 250-265. https://doi.org/10.1158/2643-3230.bcd-20-0105
Renneville, Aline, et al. "Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies." Blood cancer discovery vol. 2,3 (2021): 250-265. doi: https://doi.org/10.1158/2643-3230.bcd-20-0105
Renneville A, Gasser JA, Grinshpun DE, Jean Beltran PM, Udeshi ND, Matyskiela ME, Clayton T, McConkey M, Viswanathan K, Tepper A, Guirguis AA, Sellar RS, Cotteret S, Marzac C, Saada V, De Botton S, Kiladjian JJ, Cayuela JM, Rolfe M, Chamberlain PP, Carr SA, Ebert BL. Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies. Blood Cancer Discov. 2021 May;2(3):250-265. doi: 10.1158/2643-3230.bcd-20-0105. Epub 2021 Mar 10. PMID: 34027417; PMCID: PMC8133393.
Copy Download .nbib Format: NLM
Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies.

Blood cancer discovery

Renneville A, Gasser JA, Grinshpun DE, Jean Beltran PM, Udeshi ND, Matyskiela ME, Clayton T, McConkey M, Viswanathan K, Tepper A, Guirguis AA, Sellar RS, Cotteret S, Marzac C, Saada V, De Botton S, Kiladjian JJ, Cayuela JM, Rolfe M, Chamberlain PP, Carr SA, Ebert BL.
PMID: 34027417
Blood Cancer Discov. 2021 May;2(3):250-265. doi: 10.1158/2643-3230.BCD-20-0105. Epub 2021 Mar 10.

Thalidomide analogs exert their therapeutic effects by binding to the CRL4

Cite
Renneville A, Gasser JA, Grinshpun DE, et al. Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies. Blood Cancer Discov. 2021;2(3):250-265doi: 10.1158/2643-3230.BCD-20-0105.
Renneville, A., Gasser, J. A., Grinshpun, D. E., Jean Beltran, P. M., Udeshi, N. D., Matyskiela, M. E., Clayton, T., McConkey, M., Viswanathan, K., Tepper, A., Guirguis, A. A., Sellar, R. S., Cotteret, S., Marzac, C., Saada, V., De Botton, S., Kiladjian, J. J., Cayuela, J. M., Rolfe, M., Chamberlain, P. P., Carr, S. A., & Ebert, B. L. (2021). Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies. Blood cancer discovery, 2(3), 250-265. https://doi.org/10.1158/2643-3230.BCD-20-0105
Renneville, Aline, et al. "Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies." Blood cancer discovery vol. 2,3 (2021): 250-265. doi: https://doi.org/10.1158/2643-3230.BCD-20-0105
Renneville A, Gasser JA, Grinshpun DE, Jean Beltran PM, Udeshi ND, Matyskiela ME, Clayton T, McConkey M, Viswanathan K, Tepper A, Guirguis AA, Sellar RS, Cotteret S, Marzac C, Saada V, De Botton S, Kiladjian JJ, Cayuela JM, Rolfe M, Chamberlain PP, Carr SA, Ebert BL. Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies. Blood Cancer Discov. 2021 May;2(3):250-265. doi: 10.1158/2643-3230.BCD-20-0105. Epub 2021 Mar 10. PMID: 34027417; PMCID: PMC8133393.
Copy Download .nbib Format: NLM
Showing 1 to 9 of 9 entries